Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 826


Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.

Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4.


Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Usery JB, Vo NH, Finch CK, Cleveland KO, Gelfand MS, Self TH.

Am J Med Sci. 2015 Jan;349(1):36-41. doi: 10.1097/MAJ.0000000000000338.


Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Ariza J.

Antimicrob Agents Chemother. 2010 Dec;54(12):5251-6. doi: 10.1128/AAC.00226-10. Epub 2010 Oct 4.


Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.

Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21.


Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.

De Cock E, Krueger WA, Sorensen S, Baker T, Hardewig J, Duttagupta S, Müller E, Piecyk A, Reisinger E, Resch A.

Infection. 2009 Apr;37(2):123-32. doi: 10.1007/s15010-008-8046-7. Epub 2009 Mar 9.


In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.

Guo Y, Ramos RI, Cho JS, Donegan NP, Cheung AL, Miller LS.

Antimicrob Agents Chemother. 2013 Feb;57(2):855-63. doi: 10.1128/AAC.01003-12. Epub 2012 Dec 3.


Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.

McKinnon PS, Sorensen SV, Liu LZ, Itani KM.

Ann Pharmacother. 2006 Jun;40(6):1017-23. Epub 2006 May 23.


[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].

Grossi O, Talarmin JP, Boutoille D, Frioux R, Corvec S, Raffi F.

Med Mal Infect. 2008 Dec;38 Spec No 2:10-2. doi: 10.1016/S0399-077X(08)75153-9. French. No abstract available.


In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.

Kao TM, Wang JT, Weng CM, Chen YC, Chang SC.

J Microbiol Immunol Infect. 2011 Oct;44(5):346-51. doi: 10.1016/j.jmii.2011.01.037. Epub 2011 Jan 20.


Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.

Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP.

Antimicrob Agents Chemother. 2009 Dec;53(12):5141-4. doi: 10.1128/AAC.00307-09. Epub 2009 Oct 5.


Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.

Cadena J, Nair S, Henao-Martinez AF, Jorgensen JH, Patterson JE, Sreeramoju PV.

Antimicrob Agents Chemother. 2011 Dec;55(12):5430-2. doi: 10.1128/AAC.00706-11. Epub 2011 Sep 19.


Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.

Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.


Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.

Sipahi OR, Bardak-Ozcem S, Turhan T, Arda B, Ruksen M, Pullukcu H, Aydemir S, Dalbasti T, Yurtseven T, Sipahi H, Zileli M, Ulusoy S.

Surg Infect (Larchmt). 2013 Aug;14(4):357-62. doi: 10.1089/sur.2012.091. Epub 2013 May 14.


Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Segarra-Newnham M, Church TJ.

Ann Pharmacother. 2012 Dec;46(12):1678-87. doi: 10.1345/aph.1R370. Epub 2012 Dec 11. Review.


Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.

Sader HS, Flamm RK, Jones RN.

Antimicrob Agents Chemother. 2013 Jul;57(7):3178-81. doi: 10.1128/AAC.00484-13. Epub 2013 Apr 29.


Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.

Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA, Corey GR, Abrutyn E.

J Antimicrob Chemother. 2008 Dec;62(6):1413-21. doi: 10.1093/jac/dkn372. Epub 2008 Sep 8.


Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.

Steed ME, Vidaillac C, Rybak MJ.

Antimicrob Agents Chemother. 2010 Dec;54(12):5187-92. doi: 10.1128/AAC.00536-10. Epub 2010 Oct 4.

Items per page

Supplemental Content

Write to the Help Desk